Crescent Pharmaceuticals

Crescent Pharmaceuticals

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Crescent Pharma is a fast-growing, independent UK generic drug manufacturer and distributor, founded in 1995. It holds over 400 UK Marketing Authorisations, supplied over 200 million packs in 2022, and operates four manufacturing sites and two warehouses. The company's core mission is to support the NHS and UK healthcare by providing a reliable, cost-effective supply of generic medicines across multiple therapeutic areas.

Generic Drugs

Technology Platform

Integrated generic drug manufacturing, regulatory approval (Marketing Authorisation), and supply chain infrastructure for solid and liquid dosage forms.

Opportunities

The ongoing NHS focus on cost-saving through generics and the 'patent cliff' provide a steady stream of new market opportunities.
Increased emphasis on UK-based manufacturing for supply chain resilience could favor Crescent's domestic production footprint.

Risk Factors

Severe price competition and margin pressure in the generic drug market.
High dependence on the UK NHS and potential changes in government procurement or pricing policy.
Operational risks related to manufacturing quality and supply chain disruptions.

Competitive Landscape

Competes with large multinational generic firms (e.g., Teva, Viatris, Sandoz) and other UK-focused independents in a highly price-sensitive market. Differentiates through claimed fast growth, independent status, and a strong focus on UK supply chain reliability and NHS collaboration.